Loading
Search
▼ FOCUS: Bidding War May Break Out For Toshiba, More Business Reform Likely
- Category:Other
With a recent buyout offer for Toshiba Corp. from a British private equity firm apparently hitting a snag, a bidding war involving other investors may break out for the Japanese industrial conglomerate, industry experts say.
Investor interest in the growth potential of some of Toshiba's businesses, such as chip-making and infrastructure systems, means the company is likely to face continued pressure to streamline its wide-ranging operations, they say.
Toshiba's management rift widened after CVC Capital Partners made a buyout offer worth over $20 billion, leading its board members to believe the former president and CEO Nobuaki Kurumatani, once a CVC executive, was pulling strings to fend off pressure from activist shareholders.
Toshiba said Wednesday Kurumatani, who has led the company since 2018, offered to resign. He said in a statement he wants to take some time for himself after achieving the company's turnaround without making any reference to the CVC proposal.
Osamu Nagayama, chairman of Toshiba's board, confronted Kurumatani in the boardroom and expressed displeasure with CVC's buyout offer, sources with knowledge of the matter have said.
Nagayama and some other board members are believed to have raised questions about Kurumatani's stance of preventing activist shareholders from wielding influence.
Aiming to block CVC's acquisition plans and keep Toshiba listed on the Tokyo bourse, the conglomerate's executives asked creditor banks not to fund the private equity firm's buyout, according to people close to the matter.
CVC had previously planned to submit a detailed proposal in 10 days after sending its initial plan to Toshiba on April 6, while seeking cooperation from the Development Bank of Japan and Japan Investment Corp., a private-public sector fund, other sources have said.
But CVC did not deliver the formal offer by Friday, as it was seemingly monitoring the situation after Kurumatani's resignation with the possibility of launching a hostile takeover bid.
American global investment firm Kohlberg Kravis Roberts & Co. and Canadian investment giant Brookfield Asset Management Inc. reportedly plan to submit buyout proposals of their own.
Aiming to block CVC's acquisition plans and keep Toshiba listed on the Tokyo bourse, the conglomerate's executives asked creditor banks not to fund the private equity firm's buyout, according to people close to the matter.
CVC had previously planned to submit a detailed proposal in 10 days after sending its initial plan to Toshiba on April 6, while seeking cooperation from the Development Bank of Japan and Japan Investment Corp., a private-public sector fund, other sources have said.
But CVC did not deliver the formal offer by Friday, as it was seemingly monitoring the situation after Kurumatani's resignation with the possibility of launching a hostile takeover bid.
American global investment firm Kohlberg Kravis Roberts & Co. and Canadian investment giant Brookfield Asset Management Inc. reportedly plan to submit buyout proposals of their own.

"Investors are interested in Toshiba's chip-making affiliate Kioxia Holdings Corp.," possibly outbidding CVC, SBI Securities Co.'s senior analyst Yoshiharu Izumi said.
A global shortage of semiconductors due to robust demand for automobiles, smartphones and other electronic devices has spotlighted chipmakers.
Toshiba owns a 40.64 percent stake in Kioxia, into which the Japanese firm spun off its chip business after selling a majority stake to a consortium led by U.S. private equity firm Bain Capital in 2018. Toshiba plans to list Kioxia and use a large part of the proceeds to increase shareholder returns.
Tatsuo Ushijima, a professor specializing in corporate strategy at Keio University, said going private makes sense for Toshiba to further reform its group operations.
"Toshiba would need to review its wide-ranging businesses (from nuclear power to home lighting equipment) in an environment with fewer investors holding its shares," Ushijima said.
"Toshiba must at first outline its growth strategy regardless of whether it is going it alone or working with partners."
A global shortage of semiconductors due to robust demand for automobiles, smartphones and other electronic devices has spotlighted chipmakers.
Toshiba owns a 40.64 percent stake in Kioxia, into which the Japanese firm spun off its chip business after selling a majority stake to a consortium led by U.S. private equity firm Bain Capital in 2018. Toshiba plans to list Kioxia and use a large part of the proceeds to increase shareholder returns.
Tatsuo Ushijima, a professor specializing in corporate strategy at Keio University, said going private makes sense for Toshiba to further reform its group operations.
"Toshiba would need to review its wide-ranging businesses (from nuclear power to home lighting equipment) in an environment with fewer investors holding its shares," Ushijima said.
"Toshiba must at first outline its growth strategy regardless of whether it is going it alone or working with partners."
- April 17, 2021
- Comment (1589)
- Trackback(0)
Comment(s) Write comment
albendazole online pharmacy <a href=https://advenamed.com/drugs/mebendazole/>Mebendazole price</a> lipitor mail order pharmacy
-
Advenamed Web Site
- 28/7 03:13
canada pharmacy online legit <a href=https://bellishealth.com/medicines/vardenafil/>vardenafil buy online</a> inhouse pharmacy finasteride
-
Bellishealth Web Site
- 28/7 02:46
mexican pharmacy <a href=https://bellishealth.com/guides/gabapentin-for-nerve-pain/>gabapentin for neuropathy</a> accutane 40 mg online pharmacy
-
Bellishealth Web Site
- 27/7 19:40
pharmacy online prescription <a href=https://advenamed.com/drugs/mebendazole/>Mebendazole price</a> how much does viagra cost at the pharmacy
-
Advenamed Web Site
- 27/7 06:31
adipex online pharmacy diet pills <a href=https://advenamed.com/briefings/ciprofloxacin-when-its-worth-it/>https://advenamed.com/briefings/ciprofloxacin-when-its-worth-it/</a> pharmacy continuing education online
-
Advenamed Web Site
- 27/7 03:52
most trusted online pharmacy <a href=https://bellishealth.com/medicines/metformin/>https://bellishealth.com/medicines/metformin/</a> online pharmacy price checker
-
Bellishealth Web Site
- 27/7 03:26
clomiphene citrate online pharmacy <a href=https://bellishealth.com/>https://www.bellishealth.com/</a> clindamycin online pharmacy
-
Bellishealth Web Site
- 26/7 20:02
canadian pharmacy levitra value pack <a href=https://advenamed.com/briefings/ivermectin-uses-and-myths/>ivermectin what science says</a> reputable online pharmacy cialis
-
Advenamed Web Site
- 25/7 06:00
triamcinolone cream online pharmacy <a href=https://advenamed.com/drugs/gabapentin/>Neurontin capsules</a> can you buy misoprostol pharmacy
-
Advenamed Web Site
- 25/7 03:22
canadian pharmacy world <a href=https://bellishealth.com/medicines/vardenafil/>vardenafil 20mg</a> rx solutions pharmacy help desk
-
Bellishealth Web Site
- 25/7 02:51
discount pharmacy <a href=https://bellishealth.com/medicines/prednisone/>bellishealth.com/medicines/prednisone/</a> tesco pharmacy online viagra
-
Bellishealth Web Site
- 24/7 19:30
health partners online pharmacy <a href=https://advenamed.com/drugs/sildenafil/>sildenafil generic</a> international pharmacy no prescription
-
Advenamed Web Site
- 22/7 22:55
legitimate canadian mail order pharmacy <a href=https://advenamed.com/drugs/gabapentin/>Gabapentin 300mg</a> online pharmacy pain medication
-
Advenamed Web Site
- 22/7 20:33
atenolol people’s pharmacy <a href=https://bellishealth.com/compare/pde5-inhibitors/>pde5 comparison table</a> 24 hours pharmacy
-
Bellishealth Web Site
- 22/7 20:09




Advenamed Web Site- 28/7 05:48